UNITED THERAPEUTICS CORP (UTHR) Institutional Ownership Changes & 13F Activity

UNITED THERAPEUTICS CORP (UTHR) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Sequoia Financial Advisors, Mairs & Power Growth Fund, Hancock Classic Value, and First Eagle U.S. Value.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2022Renaissance Technologies LLCBuy28,3782,793,591$658,282
Q1 2022Renaissance Technologies LLCSell-151,9782,765,213$496,107
Q1 2022Hancock Classic ValueBuy1812,768$497
Q4 2021Renaissance Technologies LLCSell-111,4002,917,191$630,347
Q4 2021Hancock Classic ValueSell-2092,587$559
Q3 2021Renaissance Technologies LLCSell-81,6003,028,591$559,017
Q3 2021Hancock Classic ValueBuy5002,796$516
Q2 2021Renaissance Technologies LLCSell-97,4003,110,191$557,999
Q2 2021Hancock Classic ValueSell-1,9932,296$412
Q1 2021Renaissance Technologies LLCSell-399,7003,207,591$536,534
Q4 2020Renaissance Technologies LLCSell-101,7273,607,291$547,551
Q4 2020Hancock Classic ValueSell-8044,289$651
Q3 2020Renaissance Technologies LLCSell-17,8003,709,018$374,611
Q3 2020Hancock Classic ValueSell-1855,093$514
Q2 2020Renaissance Technologies LLCBuy136,5953,726,818$450,945
Q2 2020Hancock Classic ValueBuy5,2785,278$639
Q1 2020Renaissance Technologies LLCBuy45,7903,590,223$340,443
Q4 2019Renaissance Technologies LLCBuy332,1553,544,433$312,194
Q3 2019Renaissance Technologies LLCBuy171,3003,212,278$256,179
Q2 2019Renaissance Technologies LLCBuy799,2003,040,978$237,379
Q1 2019Renaissance Technologies LLCBuy45,0002,241,778$263,117
Q4 2018Renaissance Technologies LLCBuy252,7002,196,778$239,229
Q3 2018Renaissance Technologies LLCBuy410,2001,944,078$248,609
Q1 2018Renaissance Technologies LLCBuy71,5001,533,878$172,347
Q4 2017Renaissance Technologies LLCBuy189,3781,462,378$216,359
Q3 2017Renaissance Technologies LLCBuy435,4001,273,000$149,183
Q2 2017Renaissance Technologies LLCBuy331,400837,600$108,662
Q1 2017Renaissance Technologies LLCBuy85,000506,200$68,529
Q4 2016Renaissance Technologies LLCBuy31,100421,200$60,413
Q3 2016Renaissance Technologies LLCSell-14,200390,100$46,063

Frequently asked questions about UTHR activity

  • Which institutional owners are buying UTHR?

    Institutional owners buying UTHR include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in UTHR activity?

    "Buy" means an investor increased their reported position in UTHR compared to the prior reporting period. This reflects growing exposure to UNITED THERAPEUTICS CORP (UTHR) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in UTHR increasing?

    Institutional interest in UTHR can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related UTHR insights